Effects of Anti-Cytokine Antibodies on Gut Barrier Function
Anti-cytokine antibodies are used in treating chronic inflammatory diseases and autoimmune diseases such as inflammatory bowel disease and rheumatic diseases. Patients with these diseases often have a compromised gut barrier function, suggesting that anti-cytokine antibodies may contribute to the re...
Main Authors: | Fang Liu, Seul A. Lee, Stephen M. Riordan, Li Zhang, Lixin Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2019/7028253 |
Similar Items
-
Global Studies of Using Fecal Biomarkers in Predicting Relapse in Inflammatory Bowel Disease
by: Fang Liu, et al.
Published: (2020-12-01) -
Th17 Cytokines and Barrier Functions
by: Guansong Wang, et al.
Published: (2016-01-01) -
Micro Integral Membrane Protein (MIMP), a Newly Discovered Anti-Inflammatory Protein of Lactobacillus Plantarum, Enhances the Gut Barrier and Modulates Microbiota and Inflammatory Cytokines
by: Mingming Yin, et al.
Published: (2018-01-01) -
Depletion of Gut Microbiota Impairs Gut Barrier Function and Antiviral Immune Defense in the Liver
by: Weina Guo, et al.
Published: (2021-03-01) -
Intrathecal cytokine profile in neuropathy with anti‐neurofascin 155 antibody
by: Hidenori Ogata, et al.
Published: (2019-11-01)